Labshake search
Citations for Bio X Cell :
151 - 200 of 1302 citations for Rabbit anti Anti Human Immunodeficiency Virus HIV 1 Tat since 2019
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Immunology 2023Quote: ... 1 μg/ml anti-CD28 antibodies (clone 37.51, both Bio X Cell) and 10 ng/ml rhIL-2 (Peprotech ...
-
bioRxiv - Immunology 2023Quote: ... and an anti-mouse PD-1 antibody (Cat. #: BE0146, BioXCell, NH, USA), was injected intraperitoneally at the same time ...
-
bioRxiv - Immunology 2024Quote: ... with 150 μg of anti-A18 (clone 1A8, BioXCell BE-0075-1) (in 200 μl ...
-
bioRxiv - Cancer Biology 2024Quote: ... Anti-Ly6G (BioXCell) depletion antibody versus IgG isotype control was administered every other day at 200 mg/dose.
-
bioRxiv - Immunology 2022Quote: ... or combination of PD-1 and CTLA-4 using anti-PD-1 (clone: RMP1-14, BioXcell), anti-CTLA-4 (clone ...
-
bioRxiv - Bioengineering 2021Quote: ... using 100 μg of pan-specific anti-human MHC Class I (HLA-A, HLA-B, HLA-C) antibody (clone W6/32, Bio X Cell) per 1e6 cells ...
-
bioRxiv - Immunology 2021Quote: ... – and in vivo ICI treatment – anti-mouse PD-1 (RMP1-14) and anti-mouse CTLA-4 (9D9) – were purchased from Bio X Cell (USA). For T cell depletion ...
-
bioRxiv - Immunology 2023Quote: ... Autocrine production of IL-2 was neutralized by the addition of an anti-IL2 antibody (InVivoMAb anti-mouse IL-2; clone JES6-1a12; BioXcell; Cat # BE0043-1) at 10 ng/ml ...
-
bioRxiv - Cell Biology 2024Quote: ... 1 × 105 target cells were added to the 24-well BMDM plate and incubated with 1 mg/mL anti-mouse Isotype or anti-CD47 antibodies (BioXCell BE0083 and BE02830). After 2 h ...
-
bioRxiv - Cancer Biology 2022Quote: ... anti-CTLA4 and anti-2A3 were purchased from Bio X cell: Anti-mouse PD-1 (CD279 ...
-
bioRxiv - Immunology 2023Quote: ... Purified CD8+ T cells were activated by 1 μg/ml anti-CD3 (BioXCell, BP0001-1, RRID:AB 1107634) and 1 μg/ml anti-CD28 (Bio X Cell ...
-
bioRxiv - Immunology 2022Quote: ... The culture was supplemented with anti-CD28 (1 µg/mL, BioXcell, clone 37.51), TGF-β (3 ng/ml ...
-
bioRxiv - Cell Biology 2021Quote: ... InVivoMAb anti-mouse PD-1 antibody (RMP1-14, Bio X Cell, Lebanon, NH) was applied every other day at 10ug/ml culture media for 5 days ...
-
bioRxiv - Cancer Biology 2020Quote: ... injections of 200 µg of anti–PD-1 antibody (RMP1-14 clone; BioXcell) or isotype control (rat IgG2a ...
-
bioRxiv - Cancer Biology 2020Quote: ... intraperitoneal anti-CD-8 (Bio X Cell® BE0004-1 Clone 53-6.72) or control antibody was injected at a dose of 10 mg/kg on days 0 ...
-
bioRxiv - Cancer Biology 2021Quote: ... anti-PD-1 antibody (100 μg per dose, Bio X Cell, BE0033-2), 10 mg kg−1 TH-Z827 ...
-
bioRxiv - Immunology 2021Quote: ... anti-mouse PD-1 Abs (10mg/kg, clone 29F.1A12, BioXCell, Cat# BE0273) or isotype control (Clone 2A3 ...
-
Inhaled CpG increases survival and synergizes with checkpoint inhibition in lymphangioleiomyomatosisbioRxiv - Immunology 2023Quote: ... received intranasal CpG and 300 μg anti-PD-1 antibody (BioXCell, BE0146-A0) in 200 μL of PBS via intraperitoneal (IP ...
-
bioRxiv - Pathology 2023Quote: ... mice were treated with 100 μg anti- DR5 mAb (clone MD5-1; BioXCell) or given 100 μg isotype control of polyclonal Armenian hamster IgG (BE0091 ...
-
bioRxiv - Immunology 2023Quote: Antibodies used for depletion are anti-CD4 (BioXcell, clone GK1.5, Cat #BE0003-1), anti-CD8β (BioXCell ...
-
bioRxiv - Immunology 2023Quote: Blocking InVivoMab anti-mouse CD154(CD40L) antibody (Clone: MR-1; Bio X Cell) or depleting InVivoMab anti-mouse TCRbeta antibody (Clone ...
-
bioRxiv - Immunology 2023Quote: ... mice were injected ip with a depleting anti-CD4 antibody (BioxCell, BE0003-1) two days before infection ...
-
bioRxiv - Cancer Biology 2023Quote: ... Antibodies used were rat anti-mouse PD-1 IgG2a antibody (RMP1-14, BioXCell), rat anti-CD40 agonist IgG2a antibody (FGK4.5 ...
-
bioRxiv - Immunology 2024Quote: ... and/or anti-CD4 (clone GK1.5; Bio X Cell Cat. No. BE0003-1), to deplete CD8 and CD4 T cells ...
-
bioRxiv - Cancer Biology 2024Quote: ... or 200 µg anti-PD-1 (Bio X Cell: BE0146, clone RMP1-14) was administered intraperitoneally to each mouse every 3 days throughout the experiment.
-
bioRxiv - Cancer Biology 2024Quote: ... or anti-PD-1 mAb at 200 mg/dose (BioXCell, RMP-14, BE0146) every 3 days via intraperitoneal (i.p. ...
-
bioRxiv - Cancer Biology 2024Quote: ... or 1 mg mouse anti-IL-12p40 (Bio X Cell: BE0051, Clone C17.8) was administered intraperitoneally to each mouse followed by three additional doses of 500 µg of either antibody given every other day +/- either vehicle or apilimod (30 mg/kg ...
-
bioRxiv - Immunology 2023Quote: ... or Th17 – rhTGFβ (3 ng mL-1, Miltenyi) + rmIL-6 (20 ng mL-1, Miltenyi) + anti-IFNγ (10 μg mL-1, BioXcell). Cells were then transferred to uncoated tissue culture plates and cultured for an additional 3 days ...
-
bioRxiv - Immunology 2019Quote: ... Anti-CD86 CF555 was made by conjugating purified rat anti-CD86 (BioXCell) with CF555 conjugated dye from Biotium as per the manufacturers protocol.
-
CD8+ T-cell-mediated immunoediting influences genomic evolution and immune evasion in murine gliomasbioRxiv - Cancer Biology 2019Quote: ... anti-trinitrophenol (BE0089, BioXCell), one week prior to glioma induction at 0.2 mg i.p ...
-
bioRxiv - Immunology 2021Quote: ... anti-IFNγ (XMG1.2, BioXCell) and IL-4 (10,000 U/ml stock added as a supernatant from I3L6 cells(49)).
-
bioRxiv - Cancer Biology 2020Quote: ... anti-CTLA4 (9D9 BioXcell) or isotype control E.tenella-mIgG2b 10mg/kg were injected on days 0 ...
-
bioRxiv - Immunology 2022Quote: ... and anti-ICOS (BioXCell) via i.p ...
-
bioRxiv - Cancer Biology 2021Quote: ... and anti-B220 (BioXCell InVivoMab ...
-
bioRxiv - Immunology 2023Quote: ... anti-Ly6G (BioXCell, 1A8) was injected intraperitoneally at each day starting at pretreatment (In Fig.1 500µg/mouse ...
-
bioRxiv - Immunology 2023Quote: ... anti-horseradish peroxidase (BioXCell) prior to and after infection on various days ...
-
bioRxiv - Immunology 2023Quote: ... anti-IFNγ (XMG1.2; BioXCell), anti-TNFα (XT3.11 ...
-
bioRxiv - Immunology 2023Quote: ... anti-TNFα (XT3.11; BioXCell) or isotype control immunoglobulin G (IgG ...
-
bioRxiv - Cancer Biology 2023Quote: ... anti-CD8 (BioXcell, 2.43), anti-CD45 (BioLegend ...
-
bioRxiv - Cancer Biology 2023Quote: ... anti-PD1 (BioXCell # BE0146), and anti-CTLA-4 (BioXCell # BE0164 ...
-
bioRxiv - Cancer Biology 2023Quote: ... anti-CD3 (BioXcell, 17A2), and anti-CK8 (BioLegend ...
-
bioRxiv - Immunology 2023Quote: ... anti-CXCR3 (BE0249, BioXcell) and anti-IFN-γ (BE0055 ...
-
bioRxiv - Microbiology 2024Quote: ... Anti-CD8 antibody (BioXCell) or rat IgG2b isotype control (BioXCell ...
-
bioRxiv - Cancer Biology 2024Quote: ... Anti-CD8 (BioXCell, BE0061) or isotype control (BioXCell ...
-
bioRxiv - Immunology 2021Quote: ... The following antibodies were used for in vivo blocking experiments: anti-LFA-1α (M17/4) and anti-Mac-1 (M1/70) (both from Bio X Cell, West Lebanon, NH). The following antibodies or reagents were used for in vivo cell depletion ...
-
bioRxiv - Cancer Biology 2022Quote: ... 0.5 mg of pan-specific anti-human MHC Class I (HLA-A, HLA-B, HLA-C) antibody (clone W6/32, Bio X Cell [cat # BE0079]) was bound to 20 μL FastFlow Protein A Sepharose bead slurry (GE Healthcare ...
-
bioRxiv - Cancer Biology 2021Quote: ... 0.28 mg of anti-mouse CD8α antibody (clone 53-6.7, cat. #BE0004-1, BioXCell) or rat IgG (cat ...
-
PD-1 checkpoint blockade disrupts CD4 T cell regulated adaptive B cell tolerance to foreign antigensbioRxiv - Immunology 2021Quote: ... 300µg anti-mouse PD-1 antibody (clone J43, 29F.1A12 or RMP1-14, BioXcell) was administered intraperitoneal (IP) ...
-
bioRxiv - Immunology 2021Quote: ... Prophylactic treatments with anti-CSF-1 (200 µg/dose; clone: 5A1; Bio X Cell) started on day 0 p.i ...
-
bioRxiv - Pathology 2021Quote: ... injected with 500μg of anti-Gr-1 (Ly6C/G) neutralizing antibody (RB6-8C5) (BioXCell) or IgG2b isotype-matched control (BioXCell ...